HK Stock Market Move | JIAXIN INTL RES (03858) rose more than 5%, reaching a new high in stock price. It is expected to turnaround from a loss to a profit, earning over 300 million Hong Kong dollars for the whole year.
Jiaxin International Resources (03858) rose more than 5%, reaching a high of 96.85 Hong Kong dollars, setting a new record high in the market. As of the time of writing, it has risen 4.18%, to 96.05 Hong Kong dollars, with a turnover of 164 million Hong Kong dollars.
JIAXIN INTL RES (03858) rose more than 5%, reaching a high of HK$96.85, setting a new high for the listing. As of the time of writing, it rose by 4.18% to HK$96.05 with a trading volume of HK$164 million.
On the news front, JIAXIN INTL RES announced that it expects the net profit attributable to equity holders of the company to be approximately HK$300 million to HK$340 million in 2025, turning a loss into a profit year-on-year. This is mainly due to the group not being operating in 2024, resulting in a loss without any income. The group began commercial operations in April 2025, generating profits for the first time last year.
It is worth noting that according to SMM, Chongyi and other tungsten companies have announced a new round of long-term price increases. Among them, in the first half of February, a certain tungsten enterprise in Chongyi raised the purchase price of 55% tungsten concentrate by 147,000/ton to 66.9-67,000/ton, and APT raised by 30,000 to 97,000/ton, and the sharp increase in long-term prices has ignited the market again. China Post Securities stated that it is expected that tungsten prices will maintain a strong trend in the short term, focusing on changes in tungsten mine indicators and policies concerning recycled tungsten.
Related Articles

Jinling Pharmaceutical (000919.SZ) subsidiary paid back taxes of 8.4115 million yuan.

TYK MEDICINES-B(02410): The Hong Kong Stock Exchange has granted approval for the implementation of full circulation of H shares listing.

GBA DYNAMIC (01189): The listing status will be cancelled starting on February 16th.
Jinling Pharmaceutical (000919.SZ) subsidiary paid back taxes of 8.4115 million yuan.

TYK MEDICINES-B(02410): The Hong Kong Stock Exchange has granted approval for the implementation of full circulation of H shares listing.

GBA DYNAMIC (01189): The listing status will be cancelled starting on February 16th.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


